• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[必需磷脂治疗慢性肾盂肾炎]

[Essential phospholipids in the treatment of chronic pyelonephritis].

作者信息

Ovchinnikov A A, Tsvettsikh V E, Berdichevskiĭ B A, Lykov V N, Suktanbaev V R, Murychev A V

出版信息

Urol Nefrol (Mosk). 1996 Jul-Aug(4):7-9.

PMID:8928353
Abstract

The author's investigations led them to the conclusion that clinical manifestation of chronic pyelonephritis is associated with destabilization of lipid bilayer of red cell membranes, renal tissue, activation of lipid peroxidation (LPO), rising lipid and LPO products excretion with the urine. 31 patients with chronic pyelonephritis received combined therapy comprising essential phospholipids. 25 control patients with the same disease were not given essentiale-forte. Finally, the latter had longer fever duration, more active inflammation. The former had also low urine excretion of oxalates and normal lipid composition of biological membranes.

摘要

作者的研究使他们得出结论,慢性肾盂肾炎的临床表现与红细胞膜、肾组织脂质双层的不稳定、脂质过氧化(LPO)的激活、尿液中脂质和LPO产物排泄增加有关。31例慢性肾盂肾炎患者接受了包含必需磷脂的联合治疗。25例患有相同疾病的对照患者未给予易善复。最后,后者发热持续时间更长,炎症更活跃。前者尿草酸盐排泄量也较低,生物膜脂质组成正常。

相似文献

1
[Essential phospholipids in the treatment of chronic pyelonephritis].[必需磷脂治疗慢性肾盂肾炎]
Urol Nefrol (Mosk). 1996 Jul-Aug(4):7-9.
2
[Lipid peroxidation in patients with nephrolithiasis and chronic pyelonephritis in the remission stage].[肾结石和慢性肾盂肾炎缓解期患者的脂质过氧化]
Urol Nefrol (Mosk). 1995 Mar-Apr(2):21-2.
3
[Lipid peroxidation in the kidney tissue of patients with nephrolithiasis and chronic pyelonephritis].[肾结石和慢性肾盂肾炎患者肾组织中的脂质过氧化作用]
Urol Nefrol (Mosk). 1995 Sep-Oct(5):8-10.
4
[Antioxidant and membranoprotector treatment of chronic pyelonephritis].
Eksp Klin Farmakol. 2011;74(4):27-30.
5
[Lipid peroxidation in patients with hypertension and chronic pyelonephritis with arterial hypertension].[高血压患者及合并动脉高血压的慢性肾盂肾炎患者的脂质过氧化作用]
Klin Med (Mosk). 1990 Dec;68(12):20-2.
6
[Lipid peroxidation and transmembrane transport in patients with chronic pyelonephritis].[慢性肾盂肾炎患者的脂质过氧化与跨膜转运]
Urol Nefrol (Mosk). 1989 Nov-Dec(6):31-4.
7
[Lipid peroxidation and Ca-dependent ATPase activity in the microsomal fraction of renal tissue in patients with nephrolithiasis and chronic pyelonephritis].
Urol Nefrol (Mosk). 1996 Sep-Oct(5):14-6.
8
[Membrane-destabilizing processes as the universal basis of inflammation].[膜去稳定化过程作为炎症的普遍基础]
Urol Nefrol (Mosk). 1994 Mar-Apr(2):16-9.
9
[Characteristics of lipid peroxidation and activity of sympathetic nervous system in patients with chronic calculous pyelonephritis].[慢性结石性肾盂肾炎患者脂质过氧化特征及交感神经系统活性]
Urologiia. 2014 May-Jun(3):8-12.
10
[Lipids content in renal tissue membranes in patients with urolithiasis and secondary pyelonephritis].[尿路结石和继发性肾盂肾炎患者肾组织膜中的脂质含量]
Urologiia. 2005 Sep-Oct(5):56-8.